Associated Papers
Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A.
Pavic K et al.
Nature Communications, 2023
Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias.
Mäkelä E et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2021
Select a paper to view details